BioXcel Therapeutics, Inc. (BTAI) Capital expenditures 2018–2025
BioXcel Therapeutics, Inc. (BTAI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2018: $340,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $20,000 | -85.6% |
| FY2022 | $139,000 | -68.8% |
| FY2021 | $445,000 | +40.8% |
| FY2020 | $316,000 | -63.7% |
| FY2019 | $870,000 | +155.9% |
| FY2018 | $340,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice